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Abstract
Advances in protein and metabolic engineering have led to wider use of enzymes to synthesize
important molecules. However, many desirable transformations are not catalyzed by any known
enzyme, driving interest in understanding how new enzymes can be created. The cytochrome P450
enzyme family, whose members participate in xenobiotic metabolism and natural products
biosynthesis, catalyzes an impressive range of difficult chemical reactions that continues to grow
as new enzymes are characterized. Recent work has revealed that P450-derived enzymes can also
catalyze useful reactions previously accessible only to synthetic chemistry. The evolution and
engineering of these enzymes provides an excellent case study for how to genetically encode new
chemistry and expand biology’s reaction space.
Introduction
Impressive demonstrations of the use of engineered microbes to produce fuels and chemicals
in recent years have led some to predict a future in which microbes can produce nearly all of
the organic molecules upon which society depends from renewable resources [1]. This
future may be desirable from the standpoint of energy efficiency and environmental
sustainability, but it is also a ways off. Successful metabolic engineering efforts have for the
most part depended on reassembling natural enzymes into biosynthetic pathways. Many
desired products unfortunately fall outside the reach of the rather limited set of known
enzyme-catalyzed transformations. Eventually, progress in biological production will
depend on our ability to genetically encode new catalysts for known and novel chemical
reactions.
Generating new enzymes de novo is difficult, although progress is being made with some
relatively simple transformations—for example, computationally designed enzymes that
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catalyze the Kemp elimination and Diels-Alder reactions have been reported [2,3]. Nature, it
seems, agrees with this assessment, preferring to repurpose existing enzyme scaffolds rather
than create whole new enzymes [4]. Some scaffolds appear to be used more frequently than
others: for example, the enolase and crotonase superfamilies (and many others) support
several different reactions [5], whereas the dihydrofolate reductase family is only known to
carry out a single reaction [6]. Thus a biomimetic alternative to de novo protein design
might exploit enzymes that nature has already used for chemical innovations. But can
nature’s past successes with catalytic diversification guide future efforts to generate new
enzyme catalysts? Recent work suggests that the versatility of cytochrome P450 enzymes—
which catalyze a multitude of reactions in nature—can indeed be replicated and even
expanded upon by enzyme engineers to genetically encode new biosynthetic capabilities.
Cytochrome P450 enzymes are most commonly associated with the hydroxylation and
dealkylation of xenobiotic molecules in mammals, and in this case the substrate scope is
vast. But their natural roles far exceed this one niche. Biosynthetic pathways to many natural
products, such as terpenes (including steroids), alkaloids, and polyketides involve P450-
mediated oxidations, which add functional groups to simpler hydrophobic skeletons. P450s
also occur in primary catabolic pathways for degradation of alkanes and other recalcitrant
molecules. Beyond their large substrate scope, many different reaction types have been
characterized for naturally occurring and engineered P450s [7–9•], including hydroxylation,
epoxidation, sulfoxidation, aryl-aryl coupling, nitration, oxidative and reductive
dehalogenations, and recently several synthetically important non-natural reactions (vide
infra). Given future challenges in synthetic biology, the ability of P450 enzymes to assume
new catalytic functions in natural and artificial contexts merits close inspection for insights
into how we might discover or create new biocatalysts.
In this review, we present examples of the broad catalytic range of P450 enzymes from
papers published during the last two years, with an emphasis on newly characterized
reactions, both naturally occurring and artificially conceived. To help distinguish between
the many natural P450 reactions and newly discovered non-natural reactions, we first review
key aspects of P450 catalysis and describe how these characteristics allow access to a
diverse set of reactions. Next, we describe recently published non-natural P450 reactions
and contrast features of natural and non-natural chemical reactivity. Finally, we discuss the
broader relevance of P450 reaction diversity to the goal of engineering new enzymes.
Cytochrome P450: a platform for powerful C-H oxidation chemistry
Here we introduce the P450 catalytic cycle and the key reactive intermediates that are
responsible for much of the natural reactivity of P450 enzymes. Additionally, we make note
of some of the key conserved residues involved in oxygen activation; mutations to some of
these key residues lead to increased activity in non-natural reactions as we describe below.
For a more detailed treatment of the P450 mechanism, we refer the reader to more
specialized reviews [7,10•–13].
In the resting state of the enzyme, the catalytic iron is in the ferric (+3) oxidation state
(intermediate A in Figure 1). P450s produce intermediates that are sufficiently reactive to
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attack even inert hydrocarbons. Consequently, P450 enzymes have evolved mechanisms that
prevent initiation of the catalytic cycle in the absence of substrate. Substrate binding initiates
the catalytic cycle by increasing the redox potential of the heme prosthetic group, which
makes it possible for an associated reductase to reduce the heme to the ferrous (+2) state.
The catalytic cycle continues with binding of molecular oxygen to the iron center to give a
ferric superoxide complex (intermediate B in Figure 1). A second electron transfer generates
an iron-peroxo intermediate (C1 in Figure 1), which is then protonated to give an iron-
hydroperoxy intermediate (C2 in Figure 1). Subsequent protonation effects heterolytic
cleavage of the O-O bond to form the high-valent iron-oxo intermediate known as
compound I (intermediate D in Figure 1). In hydroxylation reactions, compound I abstracts a
hydrogen atom from a substrate C-H bond (formally a proton-coupled 1-electron oxidation
of the substrate) yielding compound II and a substrate radical. These two radical species
then rapidly recombine to produce the hydroxylated product and the ferric resting state of
the enzyme.
Although many interactions between the protein, its reductase partner, and heme prosthetic
group contribute to the smooth operation of the catalytic cycle, a few key residues merit
special mention. One is a conserved active-site threonine (T268 in Figure 1), which, through
water, helps to protonate the iron-peroxo and iron-hydroperoxy intermediates, thus
promoting O-O bond scission to generate compound I. Another key residue universally
conserved among P450 enzymes is the axial cysteine that ligates the heme iron. Thiolate
ligation is thought to serve several functions. For one, the electron-rich thiolate ligand makes
the ferric heme a worse electron acceptor. This decrease in redox potential helps to prevent
triggering of the catalytic cycle in the absence of substrate. Another key role of the axial
cysteine is to promote heterolytic O-O bond scission of the iron-hydroperoxy intermediate.
Finally, as Green has argued, thiolate ligation may bias compound I toward hydrogen
abstraction chemistry [12]. In particular, the electron donating ability of the thiolate ligand
makes compound I worse at performing 1-electron oxidations, but makes the 1-electron
reduced form (known as compound II) much more basic, thus favoring proton-coupled 1-
electron oxidations (i.e. hydrogen abstractions).
Intermediates in the P450 catalytic cycle drive diverse natural chemical
reactivity
The expansive catalytic scope of P450 enzymes is obvious from even a partial listing of
known P450-catalyzed reactions: aryl-aryl coupling, ring contractions and expansions, S-
N-, and O-dealkylations, decarboxylation, oxidative cyclization, alcohol and aldehyde
oxidation, desaturation, sulfoxidation, nitrogen oxidation, epoxidation, C-C bond scission,
decarbonylation, and nitration. Many of these transformations (heteroatom demethylations,
decarboxylation, alcohol and aldehyde oxidation, desaturation, and others) are
mechanistically very similar to hydroxylation (Figure 1) and result from the ability of
compound I to perform hydrogen atom abstractions; others involve compound I-mediated
oxidations distinct from hydrogen atom abstraction. P450 enzymes, however, do not rely
exclusively on compound I, as other intermediates in the catalytic cycle are responsible for
some P450 transformations (Figure 2). For example, the iron-peroxo (or hydroperoxide)
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intermediate can mediate epoxidation and sulfoxidation under some circumstances [14,15];
in others this species carries out C-C bond cleavage, as described below. Likewise, the
initial oxygen adduct with ferrous heme (the ferric-superoxide intermediate, Figure 2, blue)
is proposed to play a key role in P450-catalyzed nitration [16••]. P450 catalytic
diversification in nature is thus enabled by the generation of multiple potentially reactive
species during the P450 catalytic cycle, as well as the potency of P450-derived oxidants,
which can react with substrates in different ways. Though many potential oxidants occur
during the cycle, natural P450s are often quite specific in the reactions that they catalyze.
Specificity is directed by protein sequences molded by the force and filter of natural
selection to favor certain intermediates while tuning their reactivity and selectivity.
Beginning with compound I-derived oxidations, one particularly interesting P450-mediated
reaction occurs during biosynthesis of the natural product aureothin (Figure 2, green). The
P450 enzyme AurH first catalyzes hydroxylation of the aureothin precursor, followed by
intramolecular C-O bond formation to give a tetrahydrofuran ring, with both reactions
presumably occurring with the intermediacy of compound I [17]. Hertweck and coworkers
have exploited this unusual enzyme to accomplish a biomimetic total synthesis of aureothin,
as well as the synthesis of several aureothin derivatives [18–20•]; one paper [20•] describes
an active site mutation that converts AurH into a six-electron oxidase, leading to the
conversion of a substrate methyl group all the way to a carboxylic acid.
Several natural examples of sequential hydroxylations to yield ketones or carboxylates from
unactivated C-H bonds have been described recently [21,22]. For example, in xiamycin
biosynthesis, the P450 enzyme XiaM was shown to catalyze sequential hydroxylation of a
methyl group to a carboxylate [21]. Another example of multiple P450-catalyzed oxidations
was published by Höfer et al. in their investigation of the first steps of the biosynthesis of
bioactive alkaloids vinblastine and secologanin (Figure 2, green) [22].
Though more typical of di-iron monooxygenases and β-ketoglutarate-dependent
dioxygenases, desaturation has been observed with a few P450 enzymes [8]. An interesting
example of P450-catalyzed desaturation was recently reported by Bell et al. [23•].
CYP199A4 was previously found to catalyze demethylation of several aromatic compounds,
including 4-methoxybenzoic acid and veratric acid, as well as hydroxylation (major product)
and desaturation (minor product) of 4-ethylbenzoic acid. In their recent report, these authors
found two active site mutations (F185V and F185I) that markedly increase desaturation of 4-
ethylbenzoic acid to yield 4-vinylbenzoic acid, with the isoleucine variant giving exclusively
the desaturation product (Figure 2, green).
Several examples of P450-catalyzed decarboxylation are associated with biosynthesis and
drug metabolism. One biotechnologically interesting P450-catalyzed decarboxylation leads
to the synthesis of terminal alkenes from fatty acids [24•]. The authors propose a mechanism
in which compound I abstracts the β-hydrogen, followed by 1-electron oxidation of the
resulting radical to yield a β-carbocation, which spontaneously decarboxylates to give the
product.
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The above compound I-mediated transformations most likely proceed via hydrogen atom
abstraction. Another mechanism by which compound I can mediate oxidation is through
sequential 1-electron oxidations. Vancomycin and related antibiotics contain aryl C-C and
C-O crosslinks catalyzed by P450-mediated 1-electron oxidations (Figure 2, green). Recent
work on the biosynthesis of these antibiotics includes the solution of two crystal structures
of P450s involved in aryl coupling reactions [25,26], as well as a study that examines the
timing of P450-catalyzed crosslinking during vancomycin biosynthesis [27].
Biochemical evidence suggests that the iron-peroxo intermediate can behave as an
alternative oxidant in epoxidation and sulfoxidation reactions [14,15], though until recently
[28] theoretical studies cast doubt on its role in sulfoxidation [29]. It is generally accepted
that the iron-peroxo species is the active oxidant in C-C cleavage reactions [30]. For
example, recent work by Kincaid and coworkers supports the role of a substrate-influenced
selectivity switch that promotes the stability of the iron-peroxo species, favoring C-C lyase
chemistry for certain steroid derivatives [30] (Figure 2, pink).
One of the most interesting P450 reactions characterized recently is that of tryptophan
nitration in thaxtomin biosynthesis (Figure 2, blue) [16••]. Here, neither compound I nor the
iron-peroxo intermediate is thought to play the key role. Instead, the initial adduct between
ferrous heme and dioxygen, the ferric superoxide intermediate (Figure 1, B), is proposed to
react with in situ generated nitric oxide to form ferric peroxynitrite. The peroxynitrite
species can then decompose via one of two pathways (neither of which has been directly
supported so far). In pathway (1), peroxynitrite decomposes homolytically to yield NO2• and
an iron-ferryl intermediate (compound II). Compound II then performs a 1-electron
oxidation of tryptophan, giving a radical which recombines with NO2• to give the product.
In pathway (2), heterolytic decomposition of the ferric peroxynitrite intermediate gives the
ferric-hydroxide resting state and NO2+, which reacts with tryptophan by electrophilic
aromatic substitution.
A recently characterized reaction of uncertain mechanism is P450-catalyzed synthesis of
alkanes from fatty aldehydes to form insect protective coatings [31•]. In contrast to other
known P450-catalyzed decarboxylation or decarbonylation reactions [24•], the product here
is a fully saturated alkane. Although strong evidence that a P450 was responsible for this
reaction was first presented in the 1990s [32], only recently has the specific P450 enzyme
been identified [31•].
Manipulating conserved features of P450 catalysis allows access to
reactions not observed in nature
The diverse set of naturally occurring P450 reactions has proven a rich source of inspiration
for the field of biomimetic oxidation in synthetic chemistry. In an interesting reversal of
roles, several classic papers as well as more recent works have shown that P450s can
catalyze reactions first discovered by synthetic chemists. Unlike natural P450 reactions,
which rely on various reactive oxygen intermediates, these new P450 reactions stem from
alternative reactive species created through the use of activated reagents such as diazo
compounds and azides. Some of the inspiration for non-natural P450 reactions came from
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the rich literature on P450 model complexes. Originally synthesized as functional or
spectroscopic mimics of P450 enzymes, model P450 complexes (i.e. iron-porphyrins) were
later found to catalyze several reactions distinct from oxygen transfers. Breslow and Gelman
first demonstrated that iron-tetraphenyl porphyrin model complexes could catalyze intra-
and intermolecular nitrene transfers to form benzosultams and substituted cyclohexanes
when provided with iminoiodinane nitrene precursors [33]. Following up on this, Dawson
and coworkers found that rabbit liver P450 enzymes could catalyze low levels (< 5 total
turnovers, TTN) of the same reactions that had been described for the synthetic P450 model
[34].
More recently, our group demonstrated several new P450 reactions that had previously been
shown only for metalloporphyrins. It has been known since the 1990s that iron porphyrins
catalyze the reaction of olefins with diazo carbene precursors to yield cyclopropanes [35].
Metalloporphyrin-catalyzed cyclopropanation is thought to proceed via a metal-carbenoid
intermediate, analogous to P450 epoxidations that proceed through compound I. However, it
was only recently shown by Coelho et al. [36•] that this reaction could be catalyzed at low
levels by hemin in water as well as by several heme proteins, including P450BM3, although
at lower levels even than free hemin. The selectivities of most of the heme proteins mirrored
the trans-selectivity of hemin for the cyclopropanation of styrene with ethyl diazoacetate.
P450BM3 showed very low activity, but in contrast to the other heme proteins produced the
cyclopropane product with low but measurable enantioselectivity. Mutations in P450BM3,
including at highly conserved residues such T268, dramatically improved the productivity as
well as the diastereo- and enantioselectivity of this reaction (Figure 3A). Although in natural
P450s, this conserved active site threonine acts as a proton shuttle, for non-natural
chemistry, mutation of T268 to less bulky alanine presumably relieves steric impediments to
reactivity, as evidenced by strong alterations in the stereoselectivity of cyclopropanation;
future studies may shed light on the effect of this mutation by assaying alternative
substitutions at this position. Enzyme engineering could even overcome the natural
selectivity of the prosthetic group to achieve >90% cis selectivity. And, while free hemin
gives a racemic mixture of products, the P450BM3 cyclopropanation catalysts exhibited
enantioselectivites of up to 97%. In a second publication, Coelho and coworkers
demonstrated that mutation of the axial coordinating cysteine, universally conserved among
P450s, to serine was highly activating, particularly in vivo (vide infra) [37••]. The strong
effect of axial ligand substitution was attributed in part to the significant increase in
reduction potential (>100 mV increase) for the serine-ligated enzyme, facilitating reduction
to the active ferrous state. Axial thiolate ligation, absolutely essential for monooxygenation,
is unnecessary for this non-natural reaction. Whereas thiolate ligation is important for O-O
bond scission, no such strong electron donation is required to decompose the less-stable
diazo substrates employed by Coelho et al.
Another metalloporphyrin reaction shown to be catalyzed by P450s is C-H amination from
azides as nitrene sources (Figure 3B) [38•]. The iminoiodinane precursors that Dawson and
coworkers had used to obtain low levels of C-H amination with P450s [34] are problematic
due to their insolubility in protein-compatible solvents. Thus we tested the more atom-
efficient and convenient azide-based nitrene precursors. In spite of the fact that azide-based
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C-H amination reactions have been found to be markedly less efficient with iron-porphyrins
(as compared to cobalt or ruthenium complexes) and require high temperatures and
anhydrous conditions [39], we found that wild-type P450BM3 could catalyze low levels of
intramolecular C-H amination to yield benzosultams [38•]. As found for cyclopropanation,
enzyme engineering could improve the enantioselectivity and activity of the new C-H
amination enzymes. Indeed several of the mutations that increased cyclopropanation activity
(at the active site threonine and axial cysteine) were found to strongly modulate C-H
amination activity, leading to catalysts that were capable of catalyzing several hundred
turnovers in vitro and roughly double that amount in vivo. Here again, mutation to the
conserved axial cysteine was highly activating: its positive effect on C-H amination in vitro
was even greater than observed for cyclopropanation.
In another approach to P450-catalyzed C-N bond formation, Wang et al. have shown that
engineered P450 enzymes can also catalyze carbene N-H insertions [40•]. The reaction of
ethyl diazoacetate with a diverse set of amine acceptors was found to proceed with high
turnover numbers. Although many other C-N bond forming methodologies lead to product
mixtures via multiple nucleophilic additions, the enzyme-catalyzed N-H insertions gave only
the desired secondary amines (Figure 3C). Of note is that free hemin produces a mixture of
secondary and tertiary amines, which emphasizes the important role of the enzyme in
regulating substrate access to the reactive center.
An interesting aspect of these new reactions is that both cyclopropanation and C-H
amination proceed well in whole cells. P450BM3-derived cyclopropanation catalysts, in
particular, were more than six-fold faster when used in whole cells (on a per enzyme basis)
and catalyzed more than 60,000 total turnovers under saturating substrate concentrations
[37••]. Thus the enzyme is as good as any transition metal catalyst reported to date.
Although NADPH-driven heme reduction in vitro requires P450BM3’s reductase domain, in
whole cells the reductase was not strictly necessary: even the isolated heme domain could
catalyze over 1,000 total turnovers of styrene cyclopropanation. In the reducing environment
of anaerobic whole cells, other electron donors apparently can facilitate reduction to the
active ferrous state. For C-H amination the effect of carrying out reactions in whole cells
was less profound (roughly two-fold higher activity), perhaps due to the higher levels of
azide reduction (which competes with C-H amination) in whole cells than in vitro.
A simplifying feature of enzyme-catalyzed carbene and nitrene transfers is the enzyme’s
decreased dependence on the reductase domain for activity. For C-H amination and carbene
transfers, although initial reduction to ferrous heme is necessary, after bond formation the
heme is returned to the active ferrous state, thus eliminating the need for stoichiometric
NADPH. Decreased dependence on the reductase may also prove to be problematic as it
may lead to the generation of reactive carbon or nitrogen species in the absence of substrate,
which for stronger electrophiles may lead to heme or protein destruction.
An interesting lesson from these efforts to generate enzymes for whole new reactions is that
conserved residues whose function was highly specific to the chemistry catalyzed by the
natural enzyme became particularly important for tuning the new activities. The active site
threonine, which normally helps to catalyze O-O bond scission via protonation, and the axial
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coordinating cysteine, whose importance in oxygenation reactions is profound [12], can both
be substituted to greatly increase activity for C-H amination and cyclopropanation (and
abolish monooxygenase activity). Many other protein residues contribute to oxygen
activation in P450s, and it is likely that at least some can be mutated to further enhance non-
natural reactivity. As observed with natural P450 enzymes, enhancing the reactivity of
enzyme-carbenoid and nitrenoid intermediates may facilitate an expanded catalytic scope for
these new chemistries.
Conclusions
What information can be gleaned from the diverse natural and non-natural chemistry
catalyzed by P450 enzymes that might inform other efforts to genetically encode new
reactions? As noted above, much of the natural diversity of P450 chemistry is driven by the
reactive nature of oxygen activation intermediates. In this vein, it is worth noting that many
other natural enzymes are capable of generating highly reactive species, such as other
oxygenase enzymes (di-iron monooxygenases, Rieske monooxygenases, etc.), radical SAM
enzymes, and adenosylcolbalamin-dependent enzymes, among others [41]. Although they
may prove more difficult to engineer than P450s, these enzymes should not be overlooked in
the search for new biocatalytic transformations.
For recent non-natural P450 chemistry, the reactive intermediates derive from the reaction of
enzyme with synthetic reagents. That these reactions do not require the sophisticated P450
catalytic cycle with its well-timed reductions and bond cleavages can be attributed to the
activated nature of the reagents, which undergo relatively facile decomposition to yield
reactive carbon and nitrogen species. Exploring the reactions of synthetic reagents with
natural enzymes has proven fruitful for finding new genetically encoded catalysts in other
contexts [42–44] and is likely to bring more synthetic chemistry into biology. While the
reactivity of a free prosthetic group is not necessarily predictive of activity within an
enzyme, for each reaction type we explored thus far [36•,38•,40•], free heme was found to
give at least some basal activity with most (though not all) substrates under the assay
conditions. Thus investigations of metal/cofactor-reagent pairs may yield useful starting
points for identifying possible new enzyme reactivities. Of course, what is different from
past efforts [34] is the availability of enzyme engineering tools such as directed evolution,
which can reliably improve even very low activities, especially when the activities are
exhibited by an (evolvable) enzyme rather than some other protein framework.
Although non-natural chemistries that rely on synthetic reagents may be challenging to
employ within cellular biosynthetic pathways, a great deal of useful biocatalysis is
conducted in vitro [45] where access to the synthetic reagent is not a problem. Current
efforts to develop biosynthesis in cell-free extracts [46] could allow for relatively
straightforward integration of non-natural prosthetic groups and reagents in biosynthetic
pathways. Thus working within the constraints of biology may ultimately prove unnecessary
—even for enzyme engineers.
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Highlights
• Discovering enzymes for new reactions is important but challenging
• Cytochrome P450 enzymes catalyze many different chemical reactions in nature
• P450s can be engineered to catalyze reactions first discovered by synthetic
chemists
• Engineering enhances the activity and selectivity of P450s in non-natural
reactions
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Figure 1.
The P450 catalytic cycle. The active site structure of P450BM3 is shown at center with conserved threonine (T268) and axial
cysteine (C400) highlighted. Key intermediates include the ferric resting state (A), the ferric superoxide intermediate (B), the
iron-peroxo or hydroperoxy intermediates (C1, C2), and compound I (D).
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Figure 2.
Key catalytic intermediates in the P450 cycle and examples of chemical reactions that rely on them. In blue are highlighted the
ferric superoxide intermediate and the nitration reaction that is associated with this intermediate [16••]. In pink are highlighted
the iron-peroxo and iron-hydroperoxy intermediates and C-C bond scission [30] and sulfoxidation [14] reactions. Highlighted in
green are compound I and desaturation [23•], ring closure [17], sequential oxidation [22], and aryl coupling reactions [27].
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Figure 3.
Several recent examples of non-natural P450 reactions: (A) cyclopropanation of styrene catalyzed by P450BM3 variants [36•],
(B) intramolecular C-H amination catalyzed by P450BM3 variants expressed in whole cells [38•], and (C) intermolecular carbene
insertion into N-H bonds yielding secondary amines [40•]
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